Amoxicillin/clavulanic acid PharmSol

Medicinal product

(Invented) name

Amoxicillin/clavulanic acid PharmSol

Active substance (s)

Amoksicilinas/Klavulano rūgštis

Strength

1000 mg/200 mg

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR02, Amoxicillin and beta-lactamase inhibitor

Marketing authorisation holder

Pharmsol Europe Limited, Malta

Date of authorisation

2026-02-11

Date of renewal

Documents

Amoxicillin_clavulanic_acid_PharmSol_milt.injek._viesas_AR.pdf

5962-63 Amx_Clv_PharmSol.docx

5962-63 pakuotes lapelis_2026-02-11.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Amoksicilinas	1000 mg
Klavulano rūgštis	200 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120031	106134	1106134	flakonas	N1		Receptinis	LT/1/26/5963/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-02-11	Registruotas